Hirotsu I, Kihara T, Hattori Y, Hatta M, Hirose N, Ishihara T, Satoh F
Laboratory of Experimental Pharmacology, Suntory Institute for Biomedical Research, Osaka, Japan.
Arzneimittelforschung. 1988 Oct;38(10):1410-7.
The pharmacological actions of N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165), a new antiarrhythmic agent, on the peripheral nervous system and peripheral organs were studied in various laboratory animals in comparison with those of disopyramide and mexiletine, and the following results were obtained. 1. Large doses (50 or 100 mg/kg p.o.) of SUN 1165 as well as mexiletine had little effects on the pilocarpine-induced hypersalivation and the pupil size in mice. At higher concentration (10(-5) g/ml), SUN 1165 had no effects on the various spasmogen acetylcholine (ACh)-, histamine- or BaCl2-induced contractions in the isolated guinea pig ileum, tracheal smooth muscle and urinary bladder. Disopyramide caused mydriasis, inhibited the pilocarpine-induced hypersalivation at antiarrhythmic doses (10-30 mg/kg p.o.), and suppressed ACh-induced contractions in the various organs. 2. SUN 1165, like disopyramide and mexiletine, decreased the contractile amplitude and diastolic tone of the isolated rabbit ileum. SUN 1165 as well as disopyramide had no effect on the intestinal propulsion even at a large dose (100 mg/kg p.o.). Mexiletine inhibited it at antiarrhythmic doses (10-30 mg/kg p.o.). SUN 1165 only at a large dose (100 mg/kg i.d. or p.o.) inhibited volume of pepsin output in the gastric juice in pylorus-ligated rats and caused a damage to the gastric mucosa. 3. SUN 1165, like disopyramide and mexiletine, slightly potentiated the norepinephrine-induced contraction of the rat vas deferens in vitro. Moreover, SUN 1165 as well as disopyramide and mexiletine slightly potentiated the serotonin-induced contraction of the rat isolated fundus.(ABSTRACT TRUNCATED AT 250 WORDS)
将新型抗心律失常药物N-(2,6-二甲基苯基)-8-吡咯烷乙酰胺盐酸盐半水合物(SUN 1165)与丙吡胺和美西律进行比较,在多种实验动物中研究了其对周围神经系统和周围器官的药理作用,结果如下:1. 大剂量(50或100 mg/kg口服)的SUN 1165以及美西律对毛果芸香碱诱导的小鼠流涎过多和瞳孔大小影响很小。在较高浓度(10(-5) g/ml)时,SUN 1165对离体豚鼠回肠、气管平滑肌和膀胱中各种致痉剂乙酰胆碱(ACh)、组胺或氯化钡诱导的收缩无影响。丙吡胺导致瞳孔散大,在抗心律失常剂量(10 - 30 mg/kg口服)时抑制毛果芸香碱诱导的流涎过多,并抑制各种器官中ACh诱导的收缩。2. SUN 1165与丙吡胺和美西律一样,降低了离体兔回肠的收缩幅度和舒张张力。SUN 1165以及丙吡胺即使大剂量(100 mg/kg口服)对肠道推进也无影响。美西律在抗心律失常剂量(10 - 30 mg/kg口服)时抑制肠道推进。SUN 1165仅在大剂量(100 mg/kg皮下注射或口服)时抑制幽门结扎大鼠胃液中胃蛋白酶的分泌量,并对胃黏膜造成损伤。3. SUN 1165与丙吡胺和美西律一样,在体外轻微增强去甲肾上腺素诱导的大鼠输精管收缩。此外,SUN 1165以及丙吡胺和美西律轻微增强5-羟色胺诱导的大鼠离体胃底收缩。(摘要截短至250字)